ARCHIVES

Lenalidomide, An Altered Thalidomide, Shows Promise

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

Owens Becomes President, NCCR

June 21, 1996

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

Also NCI requests $6.2 billion in FY2005 Bypass Budget.

January 2, 2004

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980

Breast Cancer: Pitt “Regrets” Any Harm, Expresses Pride In Fisher’s Work

September 5, 1997

More Workers Quit Smoking When Health Messages Combined

August 30, 2002